The PE Ratio as of September 2024 (TTM) for Praxis Precision Medicines, Inc. (PRAX) is -10.45

According to Praxis Precision Medicines, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -10.45. This represents a change of 172.97% compared to the average of -3.83 of the last 4 quarters.

Praxis Precision Medicines, Inc. (PRAX) Historical PE Ratio (quarterly & annually)

How has PRAX PE Ratio performed in the past?

The mean historical PE Ratio of Praxis Precision Medicines, Inc. over the last ten years is -2.87. The current -10.45 PE Ratio has changed 36.27% with respect to the historical average. Over the past ten years (40 quarters), PRAX's PE Ratio was at its highest in in the March 2023 quarter at -0.29. The PE Ratio was at its lowest in in the December 2020 quarter at -16.43.

Praxis Precision Medicines, Inc. (PRAX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Praxis Precision Medicines, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Praxis Precision Medicines, Inc. (PRAX) Average PE Ratio

How has PRAX PE Ratio performed in the past?

The current PE Ratio of Praxis Precision Medicines, Inc. (PRAX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Praxis Precision Medicines, Inc. (PRAX) PE Ratio vs. Peers

How is PRAX’s PE Ratio compared to its peers?

Praxis Precision Medicines, Inc.’s PE Ratio is less than Molecular Partners AG (-2.54), less than Mineralys Therapeutics, Inc. (-4.79), less than AN2 Therapeutics, Inc. (-0.48), less than Pharvaris N.V. (-8.98), less than PepGen Inc. (-3.36), less than Theseus Pharmaceuticals, Inc. (-3.19), less than PMV Pharmaceuticals, Inc. (-1.60), less than Cullinan Oncology, Inc. (-6.52), greater than Enliven Therapeutics, Inc. (-12.94), less than Immuneering Corporation (-1.97), less than Anebulo Pharmaceuticals, Inc. (-5.80), less than Eliem Therapeutics, Inc. (-3.90), less than HCW Biologics Inc. (-0.59), less than Stoke Therapeutics, Inc. (-7.94), greater than Edgewise Therapeutics, Inc. (-13.60), greater than Crinetics Pharmaceuticals, Inc. (-16.51), greater than Dyne Therapeutics, Inc. (-12.42), greater than Revolution Medicines, Inc. (-14.06),

Build a custom stock screener for Praxis Precision Medicines, Inc. (PRAX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Praxis Precision Medicines, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Praxis Precision Medicines, Inc. (PRAX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Praxis Precision Medicines, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.